Preprint Article Version 1 This version is not peer-reviewed

Novel Intravitreal Retina-Targeting and Immune-Evading Adeno-Associated Virus Capsid Variant

Version 1 : Received: 26 September 2024 / Approved: 27 September 2024 / Online: 27 September 2024 (12:31:28 CEST)

How to cite: Cai, Z.; Liu, Y.; Zhao, L.; Li, X.; Zhang, B.; Tang, Y.; Zhou, T.; Zheng, Z.; Li, A.; Wei, J.; Ji, Q.; Lu, D.; Marsic, D. Novel Intravitreal Retina-Targeting and Immune-Evading Adeno-Associated Virus Capsid Variant. Preprints 2024, 2024092179. https://doi.org/10.20944/preprints202409.2179.v1 Cai, Z.; Liu, Y.; Zhao, L.; Li, X.; Zhang, B.; Tang, Y.; Zhou, T.; Zheng, Z.; Li, A.; Wei, J.; Ji, Q.; Lu, D.; Marsic, D. Novel Intravitreal Retina-Targeting and Immune-Evading Adeno-Associated Virus Capsid Variant. Preprints 2024, 2024092179. https://doi.org/10.20944/preprints202409.2179.v1

Abstract

Retinal diseases are an important focus of in vivo gene therapy, for which adeno-associated virus is a preferred vector. Intravitreal injection is a highly desirable delivery route because it is much simpler, safer and inexpensive than the main alternative subretinal injection. However, existing capsids have low efficiency, require high doses and are susceptible to neutralization by antibodies that are present in the vitreous. Using AAV5 as starting material, we applied a combination of directed evolution and rational design to develop PT1, a novel AAV capsid capable of efficiently transducing the retina after intravitreal injection. The most striking property of PT1 is its remarkable ability to evade preexisting neutralizing antibodies, thanks to its multiple mutations spread over large areas of the capsid surface, disrupting several epitopes. Our results suggest that PT1 has a strong potential as a useful candidate capsid for human retinal gene therapy.

Keywords

AAV; capsid; intravitreal; retina; immune evasion

Subject

Biology and Life Sciences, Biology and Biotechnology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.